Search clinical trials for: BB-301: Dose escalation phase 1b cohort 3
Total 15 results
-
Benitec Biopharma, Inc.RecruitingOculopharyngeal Muscular DystrophyUnited States
-
Phost'In TherapeuticsRecruitingGlioblastoma Multiforme | Metastatic Cancer | Advanced Solid Tumor | Malignant TumorItaly, France
-
Millennium Pharmaceuticals, Inc.Completed
-
RasCal Therapeutics, Inc.RecruitingGlioblastoma | Pancreatic Cancer | Lung Cancer | Colon Cancer | Advanced Malignant Solid Neoplasm | RAS MutationUnited States
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Avenge Bio, IncTerminatedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Primary Peritoneal Carcinoma | Neoplasm, Ovarian | Adenocarcinoma Ovary | Serous Adenocarcinoma of Ovary | Serous Adenocarcinoma of Primary Peritoneum | High Grade Serous AdenocarcinomaUnited States
-
Wugen, Inc.Not yet recruitingSquamous Cell Carcinoma of Head and Neck | Colorectal Cancer Metastatic
-
ActelionTerminated
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Viridian Therapeutics, Inc.Active, not recruitingThyroid Eye DiseaseUnited States, Spain, United Kingdom, Canada, Germany, Italy, Netherlands, Australia, France, Turkey
-
Threshold PharmaceuticalsUnknown
-
National Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic LymphomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Untreated Adult Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia,... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBlastic Plasmacytoid Dendritic Cell NeoplasmUnited States